Search

everythinglearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Entospletinib effectively prevents eye and skin GVHD in mice.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Cooling with antioxidants helps protect hair during chemotherapy.

Cepharanthine could be a strong antiviral against COVID-19.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Five FDA-approved drugs may help block COVID-19 virus entry.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Cepharanthine shows promise as a COVID-19 treatment.